Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
GLP-1 analogues, once viewed mainly as glucose-lowering drugs, are now redefining obesity treatment, cardiovascular risk management, chronic kidney disease care, MASH/NASH research, and long-term metabolic disease prevention
Even more impressive, about 86% of participants had a weight reduction of 5% or more from their baseline body weight by the end of the study
The STEP (Semaglutide Treatment Effect in People with obesity) trial program delivered landmark data
Patients who experience persistent or severe symptoms should not hesitate to seek medical attention, particularly when red-flag symptoms emerge
![Dark Paladin [DR1-EN160] Ultra Rare Coldsnap](https://cdn.shopify.com/s/files/1/0378/1125/7476/products/83f1199f-a5b4-5726-87e2-2668664c0452_490af439-d341-448a-9d9d-05ce2d15b1a6.png?v=1700514881)
